|
Over-the-Counter
|
Enforcement Policy on Marketing OTC Combination Products (CPG 7132b.16). (PDF - 294KB)
|
Final Guidance
|
05/01/84
|
|
Over-the-Counter
|
General Guidelines for OTC Combination Products (PDF - 270KB)
|
Final Guidance
|
11/01/78
|
|
Over-the-Counter
|
Label Comprehension Studies for Nonprescription Drug Products (PDF - 148KB)
|
Final Guidance
|
08/03/10
|
|
Over-the-Counter
|
Labeling OTC Human Drug Products -- Questions and Answers (PDF - 599KB)
|
Final Guidance
|
01/02/09
|
|
Over-the-Counter
|
Labeling OTC Human Drug Products -Submitting Requests for Exemptions and Deferrals (PDF - 34KB)
|
Draft Guidance
|
12/19/00
|
|
Over-the-Counter; Small Entity Compliance Guides
|
Labeling OTC Human Drug Products; Small Entity Compliance Guide (PDF - 270KB)
|
Final Guidance
|
05/12/09
|
|
Over-the-Counter
|
Labeling OTC Human Drug Products Updating Labeling in ANDAs (PDF - 32KB)
|
Draft Guidance
|
02/21/01
|
|
Over-the-Counter
|
Labeling OTC Human Drug Products Updating Labeling in RLDs and ANDAs (PDF - 30KB)
|
Final Guidance
|
10/01/02
|
|
Over-the-Counter
|
Labeling OTC Human Drug Products Using a Column Format (PDF - 57KB)
|
Final Guidance
|
12/01/00
|
|
Over-the-Counter; Small Entity Compliance Guides
|
Organ-Specific Warnings: Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for Over-the-Counter Human Use — Small Entity Compliance Guide (PDF - 176KB)
|
Final Guidance
|
08/17/10
|
|
Over-the-Counter
|
Postmarketing Adverse Event Reporting for Nonprescription Human Drug Products Marketed Without an Approved Application (PDF - 298KB)
|
Final Guidance
|
07/13/09
|
|
Over-the-Counter
|
Labeling of Nonprescription Human Drug Products Marketed Without an Approved Application as Required by the Dietary Supplement and Nonprescription Drug Consumer Protection Act: Questions and Answers (PDF - 83KB)
|
Final Guidance
|
08/13/09
|
|
Over-the-Counter
|
Time and Extent Applications for Nonprescription Drug Products (PDF - 241KB)
|
Final Guidance
|
09/28/11
|
|
Labeling;
Over-the-Counter;
Small Entity Compliance Guides
|
Topical Acne Drug Products for Over-the-Counter Human Use--Revision of Labeling and Classification of Benzoyl Peroxide as Safe and Effective (PDF - 123KB)
|
Final Guidance
|
06/21/11
|
|
Over-the-Counter
|
Upgrading Category III Antiperspirants to Category I (43 FR 46728-46731) (PDF - 583KB)
|
Final Guidance
|
10/01/78
|
|
Over-the-Counter
|
Self-Selection Studies for Nonprescription Drug Products (PDF - 160KB)
|
Final Guidance
|
04/10/13
|
|
Over-the-Counter; Small Entity Compliance Guide
|
Labeling for Bronchodilators: Cold, Cough, Allergy, Bronchodilator, And Antiasthmatic Drug Products for Over-the-Counter Human Use (Small Entity Compliance Guide)
|
Final Guidance
|
11/14/12
|
|
Over-the-counter
|
Labeling and Effectiveness Testing: Sunscreen Drug Products for Over-The-Counter Human Use — Small Entity Compliance Guide
|
Final Guidance
|
12/05/12
|